{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:42:37Z","timestamp":1792701757942,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>This study investigated empiric antibiotic treatment (EAT), guideline adherence, antibiotic streamlining and clinical outcomes in 1402 hospitalized children with pediatric parapneumonic effusion\/pleural empyema (PPE\/PE).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A nationwide surveillance study collected data on EAT, clinical course\/outcome, pathogens, susceptibility testing and antibiotic streamlining of children with PPE\/PE in Germany between 2010 and 2018. Subgroups were compared using <jats:italic toggle=\"yes\">\u03c7<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> test\/Fisher exact test, Mann\u2013Whitney <jats:italic toggle=\"yes\">U<\/jats:italic> test and linear regression analysis adjusting for patient age where appropriate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Complete data on EAT were available for 1402 children. In children with monotherapy (n = 567) and in children with combination therapy of 2 antibiotics (n = 589), the most commonly used antibiotics were aminopenicillin\/beta-lactamase inhibitor [138\/567 (24.3%) and 102\/589 (17.3%)] and cefuroxime [291\/567 (51.3%) and 294\/589 (49.9%)]. The most common combinations with these beta-lactams were macrolides, aminoglycosides and clindamycin. We observed no difference in clinical severity\/outcome between EAT with aminopenicillin\/beta-lactamase inhibitor and cefuroxime, neither when used in monotherapy nor when used in combination therapy of 2 antibiotics. Species diagnosis of <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic> (n = 192), <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic> (n = 111) or <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (n = 38) in polymerase chain reaction or culture from pleural fluid or blood resulted in a switch to an appropriate narrow-spectrum beta-lactam therapy in 9.4%, 18.9 % and 5.2% of children. In a subset of children with reported bacterial susceptibility testing, penicillin resistance was reported in 3\/63 (4.8%) of <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic> and methicillin resistance in <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> was reported in 10\/32 (31.3%) of children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study points to antibiotic overtreatment in children with PPE\/PE, particularly the frequent use of combinations of antibiotics. Children receiving combinations of antibiotics did not show differences in clinical outcomes. The low rate of children with streamlined antibiotic therapy even upon pathogen detection indicates a necessity for antibiotic stewardship measures in PPE\/PE and the need of investigating other potential therapeutic strategies as anti-inflammatory therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004359","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T19:00:11Z","timestamp":1715108411000},"page":"651-656","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Empiric Antibiotic Therapy in 1402 Children With Parapneumonic Effusion\/Pleural Empyema in Germany: A Long-term Surveillance Study"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-5891","authenticated-orcid":false,"given":"Johannes","family":"Forster","sequence":"first","affiliation":[{"name":"From the Institute for Hygiene and Microbiology, University of W\u00fcrzburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Piazza","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goettler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Lotta","family":"Tanzberger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kenntner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schoen","sequence":"additional","affiliation":[{"name":"From the Institute for Hygiene and Microbiology, University of W\u00fcrzburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Streng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes G.","family":"Liese","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/INF.0000000000003036","article-title":"Effect of prehospital antibiotic therapy on clinical outcome and pathogen detection in children with parapneumonic pleural effusion\/pleural empyema.","volume":"40","author":"Forster","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3182002d14","article-title":"Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.","volume":"30","author":"Blaschke","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","article-title":"The American Association for Thoracic Surgery consensus guidelines for the management of empyema.","volume":"153","author":"Shen","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2004.030676","article-title":"BTS guidelines for the management of pleural infection in children.","volume":"60","author":"Balfour-Lynn","year":"2005","journal-title":"Thorax"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study.","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2016.05.009","article-title":"Etiology of parapneumonic effusion and pleural empyema in children. the role of conventional and molecular microbiological tests.","volume":"116","author":"Krenke","year":"2016","journal-title":"Respir Med"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ppul.23562","article-title":"Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study.","volume":"52","author":"Segerer","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1148\/radiographics.20.3.g00ma05653","article-title":"US in the diagnosis of pediatric chest diseases.","volume":"20","author":"Kim","year":"2000","journal-title":"Radiographics"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases.","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"R14-20250614","first-page":"136","article-title":"Beta-Lactamasen und Beta-LactamaseInhibitoren.","volume":"7","author":"Theureztbacher","year":"1998","journal-title":"Chemotherapie J"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/infdis\/142.4.586","article-title":"Gentamicin inactivation in purulent exudates: role of cell lysis.","volume":"142","author":"Vaudaux","year":"1980","journal-title":"J Infect Dis"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/2014\/757963","article-title":"Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.","volume":"25","author":"Pernica","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"e2216162","DOI":"10.1001\/jamanetworkopen.2022.16162","article-title":"Effect of Point-of-Care testing for respiratory pathogens on antibiotic use in children: a randomized clinical trial.","volume":"5","author":"Mattila","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2017.02.043","article-title":"Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial.","volume":"185","author":"Tagarro","year":"2017","journal-title":"J Pediatr"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ppul.25699","article-title":"Management of parapneumonic pleural effusion in children: is there a role for corticosteroids when conventional nonsurgical management fails? A single-center 15-year experience.","volume":"57","author":"Thimmesch","year":"2022","journal-title":"Pediatr Pulmonol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:04:13Z","timestamp":1749945853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004359","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,6]]}}}